RGA and Dai-ichi Life Ink 150 Billion JPY Coinsurance Deal for 2025

Reuters
03 Jun
RGA and Dai-ichi Life Ink 150 Billion JPY Coinsurance Deal for 2025

Reinsurance Group of America, Incorporated $(RGA)$, a prominent global life and health reinsurer, has announced a significant new transaction with The Dai-ichi Life Insurance Company, Limited. The agreement involves an RGA subsidiary reinsuring 150 billion JPY of statutory reserves through coinsurance. This deal, effective March 31, 2025, marks a continuation of the successful collaboration between RGA and Dai-ichi, which began in 2020. Gaston Nossiter, RGA's Senior Vice President for Japan and Asia Pacific Financial Solutions, highlighted that this agreement underscores RGA's commitment to delivering innovative reinsurance solutions in the Asian insurance market, aimed at optimizing capital and enhancing risk management capabilities. RGA has been a leader in pioneering asset-intensive solutions as financial optimization tools and has implemented numerous successful coinsurance deals across the Asia Pacific region since 1996.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reinsurance Group of America Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250602567455) on June 02, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10